English | Español
Amanda Rupp | Jun 1, 2016

FDA approves Zinbryta to treat MS
Kim Sunderland | Jun 1, 2016

Independent Women’s Forum policy expert says more diverse health insurance plans are needed across U.S.
Amanda Rupp | Jun 1, 2016

FDA approves new diagnostic imaging agent for recurrent prostate cancer
Amanda Rupp | Jun 1, 2016

Bristol-Myers Squibb responds to ICER report
Amanda Rupp | Jun 1, 2016

First buprenorphine implant treatment for opioid dependence earns FDA approval
Amanda Rupp | Jun 1, 2016

New CMS data initiatives to improve transparency of Medicare program

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access